Akanda Corp (AKAN) has released an update.
Akanda Corp has successfully conducted its Annual General and Special Meeting, resulting in the election of four directors and the re-appointment of GreenGrowth CPAs as auditors. Shareholders approved a potential share consolidation of up to 100 pre-consolidation shares for one post-consolidation share, and confirmed a 30% evergreen 2024 Equity Incentive Plan. Additionally, a special resolution passed authorizing the sale of RPK Biopharma to Somai Pharmaceuticals.
For further insights into AKAN stock, check out TipRanks’ Stock Analysis page.
